secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001193125-25-087955
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics raises ~$5.05M via warrant exercises, exchanges, and private placement
--------------------------------------------------------------------------------

- Holders exercise 2023 and 2024 warrants for 902,929 shares at reduced price of $1.60 per share.
- Holders of 2023 warrants exchange 1,939,000 shares for pre-funded warrants plus cash payment of ~$1.599/share.
- Bios affiliate purchases pre-funded warrants for 312,695 shares at $1.599 per share in private placement.
- Total gross proceeds expected to be approximately $5.05 million.
- Pre-funded warrants are immediately exercisable at $0.001 per share, subject to beneficial ownership limit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525087955/0001193125-25-087955-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525087955/d934084d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-087955

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer